Eris Lifesciences Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
ERIS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Eris Lifesciences has informed stock exchanges that its trading window will be closed for insiders starting April 1, 2026. The closure will remain in effect until 48 hours after the company declares its audited financial results for the quarter and full financial year ending March 31, 2026. This is a routine regulatory requirement under SEBI's Insider Trading Regulations and applies to all designated persons (such as directors, senior management) and their immediate relatives. The company has not announced any financial numbers yet in this notice.
This is a standard compliance filing and not a material event on its own. It signals that the company's Q4 and FY26 earnings results are likely to be announced in the coming weeks, which investors should watch for as it may influence the stock price.